Release 5 R6 Ballot (3rd Draft)
This page is part of the FHIR Specification (v5.0.0: R5 - STU ). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Publish-box (todo)

Example ClinicalUseDefinition/example (Narrative)

Biomedical Research and Regulation Work Group Maturity Level : N/A Standards Status : Informative Compartments : No defined compartments

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition .

Generated Narrative: ClinicalUseDefinition example

Resource ClinicalUseDefinition "example"

StructureDefinition Work Group : brr

type : contraindication

subject : MedicinalProductDefinition: identifier = http://ema.europa.eu/example/MPID#{mpid}; classification = B01AF02

contraindication

DiseaseSymptomProcedures

- Concept
* Hepatic disease associated with coagulopathy and clinically relevant bleeding risk (contraindicationsasdisease-symptom-procedure#Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)) Comorbidities - Concept * Hepaticdisease (comorbidity#Hepaticdisease)

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.